Relationship between nicotine dependence and the endophenotype-related trait of cognitive function but not acoustic startle reponses in Japanese patients with schizophrenia

Human Psychopharmacology

Volumn 28, Issue 3, 2013, Pages 220-229

  Kishi, Taro ^a,b,c   Fukuo, Yasuhisa ^b   Okochi, Tomo ^b,c   Kawashima, Kunihiro ^b   Moriwaki, Masatsugu ^b,c   Furukawa, Osamu ^c   Musso, Giovanna M ^a   Fujita, Kiyoshi ^c,d   Correll, Christoph U ^a   Iwata, Nakao ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Okehazama Hospital   (Japan)

^d Neuroscience Research Center   (Japan)

Author keywords

CHRNA4 CHRNB2; cognitive function; nicotine dependence; prepulse inhibition; schizophrenia

Indexed keywords

BUNGAROTOXIN RECEPTOR; NICOTINE; NICOTINIC RECEPTOR ALPHA4; NICOTINIC RECEPTOR BETA2;

ACOUSTIC REFLEX; ACOUSTIC STARTLE RESPONSE; ADULT; AGED; ARTICLE; BRIEF ASSESSMENT OF COGNITION N SCHIZOPREHIA; COGNITION; CONTROLLED STUDY; CORRELATIONAL STUDY; ENDOPHENOTYPE; EXECUTIVE FUNCTION; FAGERSTROM TEST; FEMALE; HUMAN; JAPANESE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STARTLE REFLEX; TOBACCO DEPENDENCE; TOBACCO DEPENDENCE SCREENER; VERBAL MEMORY;

ADULT; AGED; CASE-CONTROL STUDIES; COGNITION; ENDOPHENOTYPES; EXECUTIVE FUNCTION; FEMALE; HUMANS; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; STARTLE REACTION; TOBACCO USE DISORDER;

EID: 84878247803     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2310     Document Type: Article

References (30)

1. Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX,. 2008. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33: 497-512.
2. Dome P, Lazary J, Kalapos MP, Rihmer Z,. 2010. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev 34: 295-342.
3. Dudbridge F,. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121.
4. Feng Y, Niu T, Xing H, et al,. 2004. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 75: 112-121.
5. Flores CM, Davila-Garcia MI, Ulrich YM, Kellar KJ,. 1997. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem 69: 2216-2219.
6. George TP, Termine A, Sacco KA, et al,. 2006. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res 87: 307-315.
7. Gur RE, Cowell PE, Latshaw A, et al,. 2000. Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry 57: 761-768.
8. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO,. 1991. The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86: 1119-1127.
9. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV,. 2001. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 58: 24-32.
10. Kamatani N, Sekine A, Kitamoto T, et al,. 2004. Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am J Hum Genet 75: 190-203.
11. Kaneda Y, Sumiyoshi T, Keefe R, Ishimoto Y, Numata S, Ohmori T,. 2007. Brief assessment of cognition in schizophrenia: validation of the Japanese version. Psychiatry Clin Neurosci 61: 602-609.
12. Kao YC, Liu YP, Cheng TH, Chou MK,. 2011. Cigarette smoking in outpatients with chronic schizophrenia in Taiwan: relationships to socio-demographic and clinical characteristics. Psychiatry Res 190 (2-3): 193-199.
13. Kawakami N, Takatsuka N, Inaba S, Shimizu H,. 1999. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav 24: 155-166.
14. Kay SR, Fiszbein A, Opler LA,. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.
15. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L,. 2004. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68: 283-297.
16. Kishi T, Ikeda M, Kitajima T, et al,. 2008. Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population. J Neural Transm 115: 1457-1461.
17. Kishi T, Moriwaki M, Kawashima K, et al,. 2010. Investigation of clinical factors influencing cognitive function in Japanese schizophrenia. Neurosci Res 66: 340-344.
18. Knable MB, Weinberger DR,. 1997. Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol 11: 123-131.
19. Kumari V, Sharma T,. 2002. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl) 162: 97-101.
20. Levin ED, McClernon FJ, Rezvani AH,. 2006. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184: 523-539.
21. Li MD, Beuten J, Ma JZ, et al,. 2005. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 14: 1211-1219.
22. Moriwaki M, Kishi T, Takahashi H, et al,. 2009. Prepulse inhibition of the startle response with chronic schizophrenia: a replication study. Neurosci Res 65: 259-262.
23. Powell SB, Zhou X, Geyer MA,. 2009. Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res 204: 282-294.
24. Rabin RA, Sacco KA, George TP,. 2009. Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status. Schizophr Res 114: 91-97.
25. Scholes KE, Martin-Iverson MT,. 2009. Relationships between prepulse inhibition and cognition are mediated by attentional processes. Behav Brain Res 205: 456-467.
26. Smith RC, Singh A, Infante M, Khandat A, Kloos A,. 2002. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27: 479-497.
27. Vangkilde S, Bundesen C, Coull JT,. 2011. Prompt but inefficient: nicotine differentially modulates discrete components of attention. Psychopharmacology (Berl) 218: 667-680.
28. Voineskos S, De Luca V, Mensah A, Vincent JB, Potapova N, Kennedy JL,. 2007. Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. J Psychiatry Neurosci 32: 412-416.
29. Wessel J, McDonald SM, Hinds DA, et al,. 2010. Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerstrom test for nicotine dependence. Neuropsychopharmacology 35: 2392-2402.
30. Woznica AA, Sacco KA, George TP,. 2009. Prepulse inhibition deficits in schizophrenia are modified by smoking status. Schizophr Res 112: 86-90.